Neuronetics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuronetics, Inc. on July 2, 2018. The report details corporate governance amendments executed in connection with the closing of the Company's initial public offering (IPO).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on legal and structural changes rather than financial performance.
Material Changes
On July 2, 2018, the Company filed a Ninth Amended and Restated Certificate of Incorporation and adopted Second Amended and Restated Bylaws. Key changes include:
- Authorization of 200,000,000 shares of common stock.
- Elimination of all references to previously existing series of preferred stock.
- Authorization of 10,000,000 shares of undesignated preferred stock.
- Requirement that directors may only be removed with cause and by a two-thirds vote of outstanding voting power.
- Provision that Board vacancies shall generally be filled by remaining Board members.
- Elimination of the ability for stockholders to take action by written consent in lieu of a meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, or contingencies. The document serves solely to disclose the effective date and terms of the amended corporate charter and bylaws.
Key Facts for Investor Verification
- Confirm the exact closing date of the IPO referenced in the filing.
- Verify the total number of authorized common and preferred shares post-amendment.
- Review the full text of the Ninth Amended and Restated Certificate of Incorporation (Exhibit 3.1) and Second Amended and Restated Bylaws (Exhibit 3.2) for detailed governance provisions.
- Check subsequent filings for the actual issuance of shares under the new authorization limits.